The University of Chicago Header Logo

Connection

Timothy Carll to Receptor Protein-Tyrosine Kinases

Back to Details
This is a "connection" page, showing publications Timothy Carll has written about Receptor Protein-Tyrosine Kinases.
Timothy Carll
Connection Strength
0.157
Receptor Protein-Tyrosine Kinases
  1. Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201). Clin Cancer Res. 2020 02 15; 26(4):804-811.
    View in: PubMed
    Score: 0.157
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.